scf
ubiquitin
ligas
target
protein
degrad
recruit
factor
call
fbox
protein
identifi
biplanar
dicarboxyl
acid
compound
call
inhibitor
substrat
phosphodegron
recognit
yeast
fbox
protein
inhibit
bind
ubiquitin
full
length
phosphoryl
substrat
scf
crystal
costructur
reveal
insert
blade
propel
domain
site
remot
substrat
bind
site
longrang
transmiss
interact
distort
substrat
bind
pocket
imped
recognit
key
determin
phosphodegron
mutat
bind
site
abrog
inhibitori
effect
explain
specif
alloster
inhibit
mechan
mammalian
domain
protein
may
exhibit
similar
alloster
respons
henc
repres
extens
new
class
druggabl
target
ubiquitinproteasom
system
up
mediat
intracellular
degrad
mani
protein
cascad
enzym
activ
term
serial
activ
transfer
ubiquitin
substrat
protein
enzym
also
refer
ubiquitin
ligas
specif
recogn
discret
sequenc
motif
substrat
term
degron
human
genom
encod
least
enzym
potenti
recogn
multipl
substrat
largest
class
enzym
cullinr
ligas
crl
discov
identif
multisubunit
protein
scf
complex
larg
famili
fbox
protein
recruit
substrat
core
scf
complex
via
protein
interact
domain
typic
leucin
rich
repeat
lrr
repeat
often
phosphoryl
depend
manner
scf
enzym
like
target
hundr
differ
substrat
thu
hold
untap
potenti
drug
discoveri
repeat
ancient
conserv
motif
function
mani
differ
cellular
process
tandem
array
five
eight
repeat
form
circularli
permut
domain
structur
yeast
recognit
cyclindepend
kinas
cdk
inhibitor
domain
fbox
protein
depend
phosphoryl
multipl
phosphodegron
cpd
motif
scf
also
target
substrat
includ
human
also
known
recruit
number
import
regulatori
factor
ubiquitin
includ
cyclin
e
myc
jun
notch
srebp
presenilin
haploinsuffici
tumor
suppressor
mutat
mani
cancer
type
also
like
influenc
stem
cell
renew
virtu
effect
myc
factor
given
central
role
growth
divis
sought
identifi
small
molecul
inhibit
substrat
recognit
adapt
previous
establish
fluoresc
polar
fp
assay
monitor
displac
fluoresceinlabel
cpd
peptid
k
yeast
supplementari
fig
fp
assay
achiev
zfactor
base
neg
dmso
solvent
posit
unlabel
cpd
peptid
control
screen
compound
librari
enrich
druglik
molecul
yield
hit
inhibit
interact
least
fig
two
compound
denot
strongli
inhibit
interact
full
length
prevent
ubiquitin
scf
fig
pursu
appear
caus
nonspecif
loss
complex
captur
resin
fig
correspond
acid
deriv
also
known
binol
biplanar
axial
chiral
atropisom
wide
use
scaffold
chiral
synthesi
two
hydroxyl
group
binol
substitut
carboxyl
acid
group
fig
form
acid
use
assay
undefin
racem
mixtur
rand
senantiom
noninterconvert
even
high
temperatur
less
potent
unlabel
cpd
peptid
fp
assay
ic
versu
respect
fig
inhibit
bind
andor
ubiquitin
full
length
ic
supplementari
fig
c
weaker
appar
affin
assay
may
reflect
differ
interact
peptid
full
length
substrat
affect
activ
close
relat
enzym
scf
recruit
substrat
via
domain
fbox
protein
supplementari
fig
determin
crystal
structur
bound
complex
resolut
see
supplementari
tabl
data
collect
refin
statist
unbias
differ
electron
densiti
map
reveal
bind
repeat
domain
site
distant
cpd
bind
pocket
fig
eight
repeat
motif
form
canon
propel
structur
propel
blade
consist
four
antiparallel
interven
loop
region
supplementari
fig
emb
deep
pocket
later
surfac
blade
fig
b
supplementari
fig
engag
one
two
enantiom
r
equival
binol
top
napthalen
ring
system
insert
deepli
blade
form
extens
hydrophob
contact
fig
addit
carboxyl
group
top
ring
system
hydrogen
bond
nh
group
side
chain
form
salt
bridg
side
chain
bottom
napthalen
ring
system
solvent
expos
form
stabil
coplanar
stack
interact
side
chain
van
der
waal
interact
side
chain
carboxyl
group
bottom
ring
system
also
form
ionic
interact
side
chain
structur
obviou
preexist
pocket
might
anticip
bind
mode
fig
rather
bind
pocket
induc
separ
blade
drastic
shift
linker
connect
two
blade
fig
reorient
linker
entail
shift
main
chain
massiv
shift
side
chain
buri
solventexpos
posit
fig
e
larg
conform
alter
creat
interblad
void
fill
rearrang
residu
proxim
cpd
bind
pocket
fig
e
void
fill
part
swap
side
chain
posit
normal
buri
adjac
normal
solventexpos
side
chain
consequ
rearrang
side
chain
travers
respect
posit
vacat
turn
fill
rotat
side
chain
critic
compris
part
highli
conserv
cpd
bind
infrastructur
cpd
complex
line
hydrophob
bind
pocket
within
central
pore
fig
therebi
dictat
prefer
hydrophob
residu
posit
cpd
consensu
motif
pocket
thu
sever
distort
reorient
side
chain
bound
structur
addit
hydroxyl
group
particip
stabil
hbond
interact
side
chain
one
four
invari
essenti
arg
residu
found
ortholog
stabil
orient
turn
directli
hydrogen
bond
cpd
phosphat
group
posit
thu
critic
compromis
main
bind
pocket
posit
cpd
consensu
sequenc
predict
structur
model
effect
mimick
mutat
result
reduct
affin
cpd
peptid
fig
explor
determin
interfac
two
carboxyl
acid
group
exhibit
mark
charg
complementar
guanidinium
side
chain
mutat
arg
residu
individu
ala
attenu
inhibit
least
fig
allel
bear
either
mutat
fulli
complement
function
vivo
indic
region
normal
play
critic
role
substrat
recognit
scf
catalyt
activ
supplementari
fig
investig
structur
featur
requir
inhibit
test
panel
avail
binol
analog
activ
fp
assay
supplementari
fig
c
seri
demonstr
import
napthalen
ring
system
particip
numer
hydrophob
interact
carboxyl
group
form
electrostat
interact
two
arg
residu
mutat
structureact
result
valid
bind
mode
observ
crystal
structur
next
assess
activ
toward
human
key
residu
replac
ly
cy
respect
suggest
might
resist
inhibit
prove
case
inhibit
interact
high
concentr
fig
residu
inhibitori
activ
toward
might
due
conserv
argtoli
substitut
conserv
residu
form
induc
bind
pocket
fig
supplementari
fig
align
human
domain
reveal
asid
two
surfac
arg
residu
pattern
contact
residu
often
conserv
supplementari
fig
current
explor
whether
binol
scaffold
modifi
potent
interact
human
domain
protein
subunit
heterotrimer
g
protein
transduc
signal
host
g
protein
coupl
receptor
gpcr
thoroughli
studi
domain
protein
notabl
interact
regulatori
protein
phosducin
g
subunit
heterotrimer
gprotein
transducin
also
caus
signific
structur
rearrang
adjac
wd
propel
blade
rearrang
induc
bind
pocket
ctermin
farnesyl
moieti
partner
g
subunit
may
serv
regul
membran
associ
g
complex
comparison
structur
structur
reveal
three
highli
similar
featur
first
ligandbound
form
structur
exhibit
analog
buriedtoexpos
transit
conserv
residu
apex
connector
affect
blade
fig
second
structur
show
remark
close
juxtaposit
induc
bind
pocket
farnesyl
ligand
respect
fig
third
rearrang
occur
blade
structur
two
function
unrel
evolutionarili
distant
protein
undergo
similar
induc
conform
chang
hint
alloster
respons
may
intrins
conserv
featur
domain
contrast
convent
protein
interact
inhibitor
directli
block
substrat
bind
site
inhibitor
nutlin
elicit
effect
alloster
mechan
structur
featur
domain
structur
kelch
domain
variabl
blade
number
known
structur
rang
five
eight
blade
per
domain
circular
structur
exhibit
interblad
separ
structur
toler
artifici
insert
addit
repeat
domain
may
thu
inher
suscept
disrupt
insert
appropri
configur
small
molecul
adjac
blade
although
remain
determin
whether
domain
exhibit
alloster
respons
protein
famili
ultraconserv
residu
transmit
long
rang
alloster
effect
knowledg
repres
first
exampl
domain
inhibitor
data
show
alloster
inhibit
discrimin
even
highli
relat
domain
recogn
ident
substrat
motif
may
thu
feasibl
design
inhibitor
select
particular
domain
protein
moreov
alloster
inhibitor
may
combin
convent
bind
pocket
inhibitor
increas
potenc
yeast
genom
encod
least
protein
domain
function
signal
transcript
chromatin
remodel
mrna
splice
dna
replic
repair
protein
synthesi
ubiquitin
system
autophagi
vesicl
traffick
cytoskeleton
organel
biogenesi
supplementari
tabl
human
domain
occur
least
differ
protein
perform
similarli
divers
function
supplementari
tabl
biomed
import
domain
protein
includ
fbox
protein
target
rapamycin
tor
kinas
complex
subunit
heterotrimer
g
protein
find
suggest
domain
may
gener
access
alloster
modul
small
molecul
ntermin
label
fluorescein
phosphopeptid
deriv
cyclin
e
gllptppqsg
call
cpd
synthes
wm
keck
biotechnolog
resourc
center
new
ct
nonfluoresc
label
peptid
acgllptppqsg
synthes
dalton
chemic
toronto
canada
small
molecul
purchas
maybridg
plc
cornwal
england
purifi
previous
describ
purifi
complex
pass
superdex
gel
filtrat
column
ge
healthcar
equilibr
mm
hepe
ph
mm
nacl
mm
dtt
concentr
mgml
compound
maybridg
screen
collect
librari
wwwmaybridgecom
screen
well
format
beckmancoult
integr
robot
system
mcmaster
univers
ht
laboratori
hamilton
canada
assay
contain
complex
nm
fluoresc
label
cyclin
ederiv
phosphopeptid
mm
hepe
ph
mm
nacl
mgml
bsa
mm
dtt
final
volum
per
well
librari
compound
mm
stock
dmso
ad
final
concentr
mix
incub
room
temperatur
min
sampl
excit
nm
emiss
read
nm
analyst
ht
plate
reader
molecular
devic
corp
sunnyval
ca
high
control
contain
ul
dmso
low
control
contain
unlabel
cyclin
e
peptid
dmso
final
concentr
bind
activ
calcul
averag
sampl
valu
minu
mean
low
control
divid
mean
high
control
minu
mean
low
control
compound
classifi
initi
hit
bind
valu
control
dose
respons
curv
carri
use
condit
ec
valu
calcul
previous
describ
determin
ic
perform
use
nonlinear
regress
analysi
use
sigmoid
dose
respons
equat
variabl
slope
weight
restraint
graphpad
softwar
san
diego
ca
mp
unit
normal
compound
control
bind
graphic
represent
full
length
substrat
interact
assay
compound
final
ad
ng
gst
immobil
glutathion
sepharos
resin
pb
incub
min
follow
incub
phosphoryl
h
resin
wash
time
pb
captur
protein
visual
immunoblot
ubiquitin
assay
compound
preincub
recombin
scf
min
room
temperatur
reaction
buffer
contain
mm
tri
ph
mm
mgcl
mm
atp
dtt
ubiquitin
reaction
initi
addit
recombin
previous
phosphoryl
kinas
reaction
incub
indic
time
product
detect
immunoblot
ubiquitin
scf
carri
describ
crystal
deriv
describ
previous
crystal
transfer
buffer
contain
mm
tri
ph
ammonium
sulfat
glycerol
acid
incub
room
temperatur
min
order
incorpor
crystal
lattic
cryoprotect
crystal
soak
crystal
retain
space
group
b
structur
refin
work
r
valu
r
free
supplementari
tabl
detail
data
process
refin
provid
supplementari
inform
refer
web
version
pubm
central
supplementari
materi
black
red
interact
cyclin
ederiv
phosphopeptid
fluoresc
polar
g
inhibit
curv
wt
black
green
blue
bind
cyclin
e
phosphopeptid
fp
inset
show
bind
inhibit
unlabel
cyclin
e
phosphopeptid
three
protein
inhibit
alloster
modul
human
domain
fluoresc
polar
competit
bind
curv
cerevisia
black
human
red
inset
show
inhibit
unlabel
cyclin
e
phosphopeptid
yeast
black
human
red
b
stereo
view
overlay
inhibitor
bind
site
region
cerevisia
pdb
absenc
blue
correspond
region
human
green
pdb
residu
differ
human
cerevisia
protein
label
c
stereo
view
comparison
induc
pocket
repeat
domain
bovin
transducin
subunit
top
display
superposit
blue
bound
yellow
g
subunit
dark
green
bound
bovin
retin
phosducin
pink
farnesyl
ligand
magenta
associ
g
subunit
pdb
bottom
display
superposit
unligand
form
grey
g
subunit
light
green
pdb
illustr
purpos
farnesyl
ligand
top
imag
model
lower
imag
